FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange in New York, U.S., July 29, 2019. REUTERS/Brendan McDermid
Pfizer shares jumped 10.16%, although they were off earlier highs, after the company said the vaccine was more than 90% effective in a large-scale clinical trial for which it will now seek a U.S. emergency use authorization. U.S.-listed shares of BioNTech were up 9.89%.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Oh shit, is the orange gonna take credit for this.